Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Someone said we only acquired 6%. Any one know the facts?
When it comes to OTC...
You haven't seen bad days,
Until you've been to the grays.
What's nice?
I'm waiting for the Home Depot announcement.
Does he have anything for non-stick fry pans so I won't burn my bacon in the morning?
I have found a US company that has their own designs and is priced less than Mattys stuff and has more features. If you are interested LMK, Bob
The truth hurts. Now look what you have done! LOL, again,
That being said, how much do we know about INNDs manufacturing capability, AFAIK they don't manufacture anything,
If you are in the market I just bought a pair for $500. I've used them before and I like the company. Bluetooth included.
19M volume shows much agreement. Strong support base.
Just looking at the 1 year chart tells me its time to buy. Minimum downside risk.
Are we at $1 yet?
Are we at $1 yet?
Here is another from the same mag. You may be able to search all articles.
https://bottomlineinc.com/health/cancer-treatment/new-treatment-for-blood-cancers
i took a pic on my iphone but I don't know how to put it here.
It was non hodgkins lymphoma which returned after chemo. The article made it sound like it was a common treatment. correction.....she was given 6 months to live, this was 30 months ago and she is still cancer free, article was in Bottomline Health mag. The treatment was described as removal of patients T cells and reprogramming them genetically. Then replace them into the patient. They remain active for a lifetime and success rate is 80%. Cancer was gone after 30 days.
But do they cover the use of CAR-T cells. Is it all the same treatment?
I just read another successful use of CAR-T for a different cancer after all other treatments failed. Patient was 100% free after 6 months. Company was not identified.
Has anyone looked to see if any other companies are looking at this therapy. Sans effective patent, RGBP may be the wrong choice. I believe the efficacy of this treatment will be proven BEFORE any patents are approved.
https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy/car-t-cell1.html
Apparently this therapy is well known.
Wasn't this released back in early April??
Nevermind, 2021.
The absence of commentary here STSOOM!
The absence of commentary here STSOOM!
Im new here. Whats the relationship between MULN and Canoo?
Sometimes these floaters just refuse to go down!
False bottom at a penny?
High volume, plus 9%. Whats happening?
It's like watching paint dry....
Yes! The audit firm is Dewey, Cheatum, and Howe, out of LV.
TSDS is difficult to diagnose, and even more difficult to accept.
After buying into this POS the only thing I have left is a sense of humor.
Write ON!
Yes. Bad rep. But in this case if I knew an RS was in the pipeline I would be buying even more at these prices. How many OTCs have cash flow much less profit and growth?
Now will the longs hold or buy or will the day traders take a profit and drive it back down? History says the DTers will grab their short term gains and buy back at .0050.
What is DYO.....do your own?
Based on the ratio, don't you think RGBPP is a better option?
I'll go if someone will buy my ticket!
BobinSD
I'm sure that if you are in the OTC Pinks you can harvest some losers. Just make sure you sell before one year so you can take the short term loss, larger than the long term loss.
$750,000!! Doesn't live in CA!
If they would introduce an anti-personnel model and call it "General Destruction" it might save the Ukraine and shorten the war. Just equip each drone with a lazer targeter and a set of gravity powered self-guided arrows. No enemy would be safe unless they were under cover, and the cost per kill would be a few dollars.